RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 154 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $19 | -26.9% | 14,854 | -27.3% | 0.00% | – |
| Q1 2023 | $26 | -90.4% | 20,429 | -88.7% | 0.00% | -100.0% |
| Q4 2022 | $272 | -100.0% | 181,355 | -83.3% | 0.00% | -71.4% |
| Q3 2022 | $1,278,000 | +208.7% | 1,083,635 | +681.4% | 0.01% | +366.7% |
| Q1 2022 | $414,000 | +4.8% | 138,674 | -7.2% | 0.00% | +50.0% |
| Q4 2021 | $395,000 | -39.8% | 149,377 | -17.4% | 0.00% | -50.0% |
| Q3 2021 | $656,000 | +1071.4% | 180,819 | +1279.7% | 0.00% | +300.0% |
| Q2 2021 | $56,000 | -40.4% | 13,106 | -52.7% | 0.00% | 0.0% |
| Q1 2021 | $94,000 | -52.3% | 27,696 | -51.0% | 0.00% | -75.0% |
| Q4 2020 | $197,000 | +756.5% | 56,486 | +411.5% | 0.00% | +300.0% |
| Q4 2019 | $23,000 | -17.9% | 11,043 | -9.5% | 0.00% | -75.0% |
| Q4 2018 | $28,000 | – | 12,208 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 9,105,691 | $30,140,000 | 5.99% |
| Sio Capital Management, LLC | 1,888,181 | $6,250,000 | 3.50% |
| DAFNA Capital Management LLC | 473,478 | $1,567,000 | 1.32% |
| Cormorant Asset Management, LP | 2,000,000 | $6,620,000 | 0.96% |
| Ghost Tree Capital, LLC | 1,100,000 | $3,641,000 | 0.68% |
| Rhenman & Partners Asset Management AB | 1,282,000 | $4,243,000 | 0.67% |
| Palo Alto Investors LP | 4,254,623 | $14,083,000 | 0.67% |
| NEA Management Company, LLC | 3,243,150 | $10,375,000 | 0.36% |
| Telemetry Investments, L.L.C. | 170,000 | $563,000 | 0.25% |
| NJ State Employees Deferred Compensation Plan | 355,000 | $1,175,000 | 0.22% |